Structure‐Function Analysis of the S‐Glycosylation Reaction in the Biosynthesis of Lincosamide Antibiotics
The S-glycosyltransferase LmbT is the only known enzyme that catalyzes the incorporation of ergothioneine, 1, into secondary metabolites. The structure and function analysis of LmbT provided a structural basis for the SN2-like S-glycosylation reaction with ergothioneine. These findings will lead to the mechanistic understanding of key enzyme reactions in the biosynthesis of ergothioneine-containing natural products such as lincomycin A.
Abstract
The S-glycosyltransferase LmbT, involved in the biosynthesis of lincomycin A, is the only known enzyme that catalyzes the enzymatic incorporation of rare amino acid L-ergothioneine (EGT) into secondary metabolites. Here, we show the structure and function analyses of LmbT. Our in vitro analysis of LmbT revealed that the enzyme shows promiscuous substrate specificity toward nitrogenous base moieties in the generation of unnatural nucleotide diphosphate (NDP)-D-α-D-lincosamides. Furthermore, the X-ray crystal structures of LmbT in its apo form and in complex with substrates indicated that the large conformational changes of the active site occur upon binding of the substrates, and that EGT is strictly recognized by salt-bridge and cation-π interactions with Arg260 and Trp101, respectively. The structure of LmbT in complex with its substrates, the docking model with the EGT-S-conjugated lincosamide, and the structure-based site-directed mutagenesis analysis revealed the structural details of the LmbT-catalyzed SN2-like S-glycosylation reaction with EGT.




